Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Am Anim Hosp Assoc ; 51(4): 231-8, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26083443

RESUMEN

This was a multi-institutional retrospective study evaluating the outcome and clinical parameters associated with the postoperative prognosis of 36 cats with splenic mast cell tumors treated with splenectomy. Clinical parameters reviewed included signalment, clinical history, results of staging tests, surgical variables, administration of blood products, presence of metastasis, postoperative complications, administration of chemotherapy postoperatively, chemotherapy protocol, and response to chemotherapy. Overall median survival time was 390 days (range, 2-1737 days). Administration of a blood product (P < .0001), metastasis to a regional lymph node (P = .022), and evidence of either concurrent or historical neoplasia (P = .037) were negatively associated with survival. Response to chemotherapy (P = .0008) was associated with an improved median survival time. Larger-scale prospective studies evaluating different chemotherapy protocols are required to elucidate the discrepancy between lack of survival benefit with administration of chemotherapy and improvement in survival time with positive response to chemotherapy.


Asunto(s)
Enfermedades de los Gatos/cirugía , Mastocitoma/veterinaria , Esplenectomía/veterinaria , Neoplasias del Bazo/veterinaria , Animales , Antineoplásicos/uso terapéutico , Enfermedades de los Gatos/tratamiento farmacológico , Enfermedades de los Gatos/mortalidad , Gatos , Femenino , Masculino , Mastocitoma/tratamiento farmacológico , Mastocitoma/mortalidad , Mastocitoma/cirugía , Atención Perioperativa/veterinaria , Pronóstico , Estudios Retrospectivos , Esplenectomía/mortalidad , Neoplasias del Bazo/tratamiento farmacológico , Neoplasias del Bazo/mortalidad , Neoplasias del Bazo/cirugía
2.
Dev Biol ; 266(2): 399-416, 2004 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-14738886

RESUMEN

The Caenorhabditis elegans genome encodes 284 nuclear receptor (NR) genes. Among these 284 NR genes are 15 genes conserved among the Metazoa. Here, we analyze the expression and function of eight heretofore uncharacterized conserved C. elegans NR genes. Reporter gene analysis demonstrates that these genes have distinct expression patterns and that a majority of the C. elegans cell types express a conserved NR gene. RNA interference with NR gene function resulted in visible phenotypes for three of the genes, revealing functions in various processes during postembryonic development. Five of the conserved NR genes are orthologs of NR genes that function during molting and metamorphosis in insects. Functional studies confirm a role for most of these 'ecdysone cascade' NR orthologs during the continuous growth and dauer molts. Transcript levels for these genes fluctuate in a reiterated pattern during the molting cycles, reminiscent of the expression hierarchy observed in the insect ecdysone response. Together, these analyses provide a foundation for further dissecting the role of NRs in nematode development as well as for evaluating conservation of NR functions among the Metazoa.


Asunto(s)
Caenorhabditis elegans/genética , Genes de Helminto , Receptores Citoplasmáticos y Nucleares/genética , Receptores Citoplasmáticos y Nucleares/metabolismo , Animales , Caenorhabditis elegans/citología , Caenorhabditis elegans/fisiología , Ecdisona/metabolismo , Genes Reporteros , Proteínas Fluorescentes Verdes , Humanos , Proteínas Luminiscentes/genética , Proteínas Luminiscentes/metabolismo , Muda/fisiología , Fenotipo , Interferencia de ARN
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA